1. Home
  2. IBRX vs HLI Comparison

IBRX vs HLI Comparison

Compare IBRX & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.63

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$128.99

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
HLI
Founded
2014
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.7B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
IBRX
HLI
Price
$7.63
$128.99
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$12.57
$194.29
AVG Volume (30 Days)
8.5M
951.0K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
1.54%
EPS Growth
38.71
6.87
EPS
N/A
1.15
Revenue
$113,288,000.00
$2,617,516,000.00
Revenue This Year
$88.59
$13.77
Revenue Next Year
$131.15
$12.10
P/E Ratio
N/A
$112.22
Revenue Growth
668.31
9.55
52 Week Low
$1.95
$112.83
52 Week High
$12.43
$211.78

Technical Indicators

Market Signals
Indicator
IBRX
HLI
Relative Strength Index (RSI) 49.70 47.00
Support Level $6.68 $112.83
Resistance Level $8.46 $144.92
Average True Range (ATR) 0.33 4.40
MACD 0.06 0.47
Stochastic Oscillator 58.28 58.31

Price Performance

Historical Comparison
IBRX
HLI

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: